Announcements Trials

Browse Landscape

Phase

Phase NA 6 Phase EARLY_PHASE1 4 Phase 3 3 Phase 1 3 Phase 2 2 Phase 4 1 Phase 2/3 1 Phase 1/2 1

Status

Recruiting 5 Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 24 Carcinoma, Non-Small-Cell Lung 20 Neoplasms 19 Colorectal Neoplasms 19 Recurrence 17 Pancreatic Neoplasms 17 Multiple Myeloma 15 Advanced Solid Tumors 13 Prostatic Neoplasms 12 Advanced Solid Tumor 12 Stomach Neoplasms 10 Ovarian Neoplasms 10 Leukemia, Myeloid, Acute 10 Carcinoma, Hepatocellular 10 Triple Negative Breast Neoplasms 8 Neoplasm Metastasis 7 Melanoma 7 Squamous Cell Carcinoma of Head and Neck 6 Small Cell Lung Carcinoma 6 Lymphoma, Large B-Cell, Diffuse 6 Head and Neck Neoplasms 6 Glioblastoma 6 Urinary Bladder Neoplasms 5 Solid Tumors 5 Solid Tumor 5 Lymphoma, B-Cell 5 Lung Neoplasms 5 Liver Neoplasms 5 Glioma 5 Endometrial Neoplasms 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × Myasthenia Gravis × Clear all

NCT07372807 2026-01-28

RIPERT-MG

Xinqiao Hospital of Chongqing

Phase 1/2 Not yet recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡